Centre for Reviews and Dissemination

Research output

Research output per year 1988 1998 1999 2000 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

• 1639 Article
• 291 Commissioned report
• 187 Review article
• 111 Comment/debate
• 250 More
  • 60 Chapter
  • 48 Letter
  • 24 Editorial
  • 17 Book
  • 17 Paper
  • 17 Other contribution
  • 13 Literature review
  • 11 Conference contribution
  • 7 Poster
  • 6 Other report
  • 5 Abstract
  • 5 Book/Film/Article review
  • 5 Web publication/site
  • 4 Meeting abstract
  • 2 Short survey
  • 2 Special issue
  • 2 Doctoral Thesis
  • 2 Preprint
  • 1 Entry for encyclopedia/dictionary
  • 1 Other chapter contribution
  • 1 Master's Thesis

Research output per year

Research output per year

Search results

• 2022

  Treatment and rehabilitation of Long COVID: a scope of the RCT literature: July 2022

  Raine, G. A., Khouja, C. L., Khatwa, M., Sutcliffe, K. & Sowden, A. J., Jul 2022, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 17 p.

  Research output: Book/Report › Commissioned report

  Open Access

  File

• Upadacitinib for treating active ankylosing spondylitis: A Fast Track Appraisal. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Walker, R. A. E., Corbett, M. S., Beresford, L., Anwer, S., Duarte, A. I., Fulbright, H. A., Phung, H., Soares, M. O., Rothery, C., Walton, M. J. & Dias, S., 2022, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2021

  Avatrombopag in combination for treating chronic immune thrombocytopenia. Evidence Review Group Report for the National Institute for Health and Care Excellence.

  Cox, E. M., Corbett, M. S., Saramago Goncalves, P., Melton, H. A., Harden, M., Walker, S. M., Dias, S., Rothery, C. & Eastwood, A. J., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis

  Hodgson, R., Sharif, S., Beresford, L., Anwer, S., Walton, M. J., Wittmann, M., Harden, M., Khouja, C. L. & Dias, S., 3 Mar 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia: A Single Technology Appraisal

  Claxton, L., Corbett, M. S., Walton, M. J., Murphy, P. J., Anwer, S., Harden, M. & Dias, S., 11 Feb 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Cenobamate for adjunctive treatment of focal epilepsy: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Jankovic, D., Llewellyn, A., Anwer, S., Harden, M., Faria, R., Rothery, C., Eastwood, A. J. & Saramago Goncalves, P. R., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Daratumumab in combination for newly diagnosed systemic amyloid light-chain amyloidosis: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Faria, R., Rodgers, M., Saramago Goncalves, P. R., Anwer, S., Fulbright, H. A., Lachmann, H., Wechalekar, A., Dias, S. & Rothery, C., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs

  Duarte, A. I., Corbett, M. S., Melton, H. A., Wright, K., Soares, M. O., Rothery, C. & Simmonds, M. C., 4 Mar 2021

  Research output: Book/Report › Commissioned report

• Meta-Analysis: Guideline Methodology Document 1

  Daly, C., Dias, S., Welton, N. J., Anwer, S. & Ades, A. E., Jan 2021, NICE Guidelines Technical Support Unit. 39 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Meta-Analysis of Continuous Outcomes: Guideline Methodology Document 2

  Daly, C., Welton, N. J., Dias, S., Anwer, S. & Ades, A. E., Jan 2021, NICE Guidelines Technical Support Unit. 49 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Meta-Analysis of Event Outcomes: Guideline Methodology Document 3

  Daly, C., Anwer, S., Welton, N. J., Dias, S. & Ades, A. E., Jan 2021, NICE Guidelines Technical Support Unit. 38 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Ravulizumab for atypical Haemolytic Uremic Syndrome: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Nikolaidis, G., Llewellyn, A., Schmitt, L. H. M., Meader, N., Walker, S. M., Harden, M., Rothery, C. & Eastwood, A. J., 2021, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2020

  CHTE2020 sources and synthesis of evidence: update to evidence synthesis methods

  Welton, N. J., Phillippo, D., Owen, R., Jones, H., Dias, S., Bujkiewicz, S., Ades, A. E. & Abrams, K. R., 10 Nov 2020, NICE Decision Support Unit. 98 p.

  Research output: Book/Report › Commissioned report

  Open Access

• COVID-19: living map of the evidence

  Lorenc, T., Khouja, C. L., Raine, G. A., Shemilt, I., Sutcliffe, K., D'Souza, P., Kwan, I., Thomas, S., Wright, K., Sowden, A. J. & Thomas, J., 18 Mar 2020, EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 1 p.

  Research output: Book/Report › Commissioned report

• Entrectinib for treating NTRK fusion-positive solid tumours

  Hodgson, R., Llewellyn, A., Murphy, P. J., Claxton, L., Beresford, L., Walton, M. J., Glynn, D., Wright, K. & Dias, S., 12 Aug 2020, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Galcanezumab for preventing migraine

  Meader, N., Murphy, P. J., Dias, S., Wright, K. & Hodgson, R., 18 Nov 2020, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• KTE-X19 for treating relapsed or refractory mantle cell lymphoma: Evidence Review Group Report for the National Institute for Health and Care Excellence

  Nikolaidis, G., Murphy, P. J., Jankovic, D., Llewellyn, A., Palmer, S. J., Wright, K., Eastwood, A. J. & Faria, R., 2020, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Larotrectinib for treating NTRK fusion-positive advanced solid tumours: Single Technology Appraisal Evidence Assessment Group report for the Evidence Review Group Report for the National Institute for Health and Care Excellence

  Duarte, A. I., Corbett, M. S., Grosso, A., Walker, R. A. E., Harden, M., Bojke, L. & Simmonds, M. C., 2020, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• 2019

  A systematic review of qualitative studies of older people’s experiences of everyday travel: Project Final Report

  Graham, H. M., De Bell, S., Flemming, K. A., Sowden, A. J., White, P. C. L. & Wright, K., 16 Jan 2019, Public Health Research Consortium.

  Research output: Book/Report › Commissioned report

  Open Access

  File

• Caffeinated energy drinks and effects in UK young people: a secondary analysis of population-level datasets

  Thomas, J., Sowden, A. J., Brunton, G., Kneale, D. & Sutcliffe, K., 3 Apr 2019, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.

  Research output: Book/Report › Commissioned report

• Caffeinated energy drink use and effects in young people: a rapid overview of systematic reviews

  Brunton, G., Khouja, C. L., Raine, G. A., Stansfield, C., Kwan, I., Sowden, A. J., Sutcliffe, K. & Thomas, J., Jan 2019, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 94 p.

  Research output: Book/Report › Commissioned report

• Cerliponase alfa for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2)

  Walton, M. J., O'Connor, J., Meader, N., Claxton, L., Harden, M., Woolacott, N. F. & Hodgson, R., 27 Nov 2019, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Certolizumab pegol for treating moderate to severe plaque psoriasis

  Walton, M. J., Sharif, S., Claxton, L., Wade, R., Hodgson, R., Harden, M. & Eastwood, A. J., 17 Apr 2019, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant

  Hodgson, R., O'Connor, J., Walton, M. J., Biswas, M. & Woolacott, N. F., 31 Jul 2019, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2018

  Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma, mediastinal B-cell lymphoma and follicular lymphoma. Single Technology Appraisal Evidence Assessment Group report

  Corbett, M. S., Duarte, A. I., Melton, H. A., Walker, S. M., Wright, K., Eastwood, A. J. & Palmer, S. J., 2018, 674 p.

  Research output: Book/Report › Commissioned report

  Open Access

• Ceritinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

  Claxton, L., Woolacott, N. F., O'Connor, J., Wright, K. & Hodgson, R., 24 Jan 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Gemtuzumab ozogamicin for untreated acute myeloid leukaemia

  Wade, R., Claxton, L., Walker, R. A. E., Altunkaya, J., Soares, M. O., Wright, K., Hodgson, R., Simmonds, M. C. & Palmer, S. J., 14 Nov 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Liposomal cytarabine and daunorubicin for untreated acute myeloid leukaemia

  Claxton, L., Llewellyn, A., Biswas, M., Hodgson, R., Stewart, L., Harden, M. & Wade, R., 19 Dec 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Midostaurin for untreated acute myeloid leukaemia

  Hodgson, R., Biswas, M., Mebrahtu, T., Morgan, P. J., Harden, M. & Woolacott, N. F., 13 Jun 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Self-care for minor ailments: Systematic reviews of qualitative and quantitative research

  Richardson, M., Khouja, C. L., Sutcliffe, K., Hinds, K., Brunton, G., Stansfield, C. & Thomas, J., Jun 2018, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 161 p.

  Research output: Book/Report › Commissioned report

• The effective, safe and appropriate use of anticoagulation medicines: A systematic overview of reviews

  Brunton, G., Richardson, M., Stokes, G., Blanchard, L., Burchett, H., Khatwa, M., Khouja, C. L., Walker, R. A. E., Wright, K., Sowden, A. J. & Thomas, J., May 2018, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 189 p.

  Research output: Book/Report › Commissioned report

• Tisagenlecleucel-T for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years

  Walton, M. J., Sharif, S., Claxton, L., Wright, K., Hodgson, R. & Simmonds, M. C., 21 Dec 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Tisagenlecleucel-T for treating relapsed or refractory diffuse large B-cell lymphoma: Single Technology Appraisal Evidence Assessment Group report

  Corbett, M. S., Duarte, A. I., Walker, S. M., Wright, K., Simmonds, M. C. & Palmer, S. J., 2018, 609 p.

  Research output: Book/Report › Commissioned report

  Open Access
• 2017

  Brodalumab for treating moderate to severe plaque psoriasis. Evidence Review Group Report for the National Institute for Health and Care Excellence

  South, E., Wade, R., Grosso, A., Saramago Goncalves, P. R., Schmitt, L. H. M., Rothery, C., Wright, K. & Palmer, S. J., 2017, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Eliglustat for treating type 1 Gaucher disease

  Hodgson, R., Morgan, P. J., Yang, H., Hodkinson, A., Harden, M. & Woolacott, N. F., 28 Jun 2017, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Etirinotecan pegol for treating breast cancer with brain metastases

  Claxton, L., Wade, R., Sharif, S., Harden, M., Woolacott, N. F. & Hodgson, R., 11 Jul 2017, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Prevention interventions for Lyme disease: A systematic review

  Richardson, M., Khouja, C. L., Walker, R. A. E., Sutcliffe, K., Stansfield, C., Harden, M., Sowden, A. J. & Thomas, J., Dec 2017, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 71 p.

  Research output: Book/Report › Commissioned report

• - Sutcliffe K, Sowden A, Burchett H, Stansfield C, Harden M, Thomas J. Patient, clinician and researcher experiences of the treatment and management of Lyme disease: a systematic review

  Sutcliffe, K., Sowden, A. J., Burchett, H., Stansfield, C., Harden, M. & Thomas, J., Dec 2017, London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.

  Research output: Book/Report › Commissioned report

• Ustekinumab for treating moderately to severely active CD after prior therapy

  Hodgson, R., Biswas, M., Mebrahtu, T., Walton, M. J., Harden, M. & Woolacott, N. F., 12 Jul 2017, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2016

  Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer

  Hodgson, R., Biswas, M., Morgan, P. J., Mebrahtu, T., Harden, M. & Woolacott, N. F., 28 Sept 2016, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• NICE DSU Technical Support Document 18: Methods for population-adjusted indirect comparisons in submissions to NICE

  Phillippo, D., Ades, T., Dias, S., Palmer, S., Abrams, K. R. & Welton, N. J., 1 Dec 2016, NICE Decision Support Unit. (Technical Support Documents)

  Research output: Book/Report › Commissioned report

• Ruxolitinib for disease-related splenomegaly or symptoms in adults with myelofibrosis (review of TA289)

  Hodgson, R., Wade, R., Biswas, M., Harden, M. & Woolacott, N. F., 23 Mar 2016, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2015

  Communicating the benefits and risks of ultraviolet light to the general population: effectiveness and cost-effectiveness review.

  Fitzgerald, A., Cikalo, M., Lethaby, A., Mahon, J., Hodgson, R., Brown, S., Patterson, J., Sreekanta, A., Burley, V., Wood, H., Edwards, M. & Glanville, J., 2015, National Institute for Health and Clinical Excellence.

  Research output: Book/Report › Commissioned report

• Dinutuximab for treating high-risk neuroblastoma. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Saramago Goncalves, P. R., Simmonds, M. C., Biswas, M., Wright, K., Woolacott, N. F. & Rothery, C., 2015, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Evidence Review Group's Report: Vortioxetine for treating major depressive disorder. Report to NICE.

  Simmonds, M. C., Lomas, J. R. S., Llewellyn, A. R., Soares, M. F. O., Wright, K., Eastwood, A. J. & Palmer, S. J., 2015, NICE. 151 p.

  Research output: Book/Report › Commissioned report

• Evidence Review Group's Report: Daclatasvir for treating chronic hepatitis C. Report to NICE.

  Woods, B., Llewellyn, A., Faria, R., Lomas, J., Harden, M., Woolacott, N. F. & Griffin, S., 2015, NICE. 230 p.

  Research output: Book/Report › Commissioned report

• Impact of antiretroviral therapy on liver disease progression and mortality in patients co-infected with HIV and hepatitis C: Systematic review and meta-analysis

  Llewellyn, A., Simmonds, M. C., Brunton, G. & Sowden, A. J., 2015, EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London. 67 p.

  Research output: Book/Report › Commissioned report

• ‘Communicating the benefits and risks of ultraviolet light to the general population: cost effectiveness model technical report

  Hodgson, R., Carpenter, I., Jenks, M., Dickinson, S. & Taylor, M., 2015, National Institute for Health and Clinical Excellence.

  Research output: Book/Report › Commissioned report

• 2014

  Service user engagement and health service reconfiguration

  Dalton, J. E., Chambers, D., Harden, M., Street, A. D., Parker, G. M. & Eastwood, A. J., Sept 2014, Centre for Reviews and Dissemination/ Centre for Health Economics. 132 p.

  Research output: Book/Report › Commissioned report
• 2013

  Aflibercept in combination with irinotecan and fluorouracil-based therapy for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy: A Single Technology Appraisal.

  Wade, R., Duarte, A. I., Simmonds, M. C., Rodriguez-Lopez, R., Duffy, S., Spackman, E. & Woolacott, N. F., 2013, NICE.

  Research output: Book/Report › Commissioned report